期刊文献+

二甲双胍治疗单纯性肥胖伴脂代谢异常的效果观察 被引量:2

原文传递
导出
摘要 目的探讨二甲双胍治疗单纯性肥胖伴脂代谢异常的效果。方法选取收治的单纯性肥胖伴脂代谢异常患者92例作为研究对象,采用随机数字表法将患者分为对照组和观察组,对照组给予行为干预,观察组在对照组基础上给予二甲双胍治疗,评估两组肥胖疗效,记录两组治疗前后肥胖相关指标和血脂相关指标变化。结果观察组治疗总有效率为86.96%显著高于对照组69.57%,差异显著(P<0.05);观察组治疗后臀围、BMI、FAT分别为(101.37±4.69)cm、(27.01±1.03)kg/m2、(30.01±2.41)%,均显著低于对照组,具有统计学意义(P<0.05);观察组治疗后TG、TC、、LDL-C分别为(1.32±1.13)mmol/L、(4.28±1.13)mmol/L、(2.33±1.04)mmol/L显著低于对照组,HDL-C为(2.14±0.58)mmol/L显著高于对照组,具有统计学意义(P<0.05)。结论二甲双胍治疗单纯性肥胖伴脂代谢异常安全有效。
作者 赵雪勤
出处 《医药论坛杂志》 2016年第7期152-153,共2页 Journal of Medical Forum
  • 相关文献

参考文献5

二级参考文献39

  • 1Zou CC,Liang L,Hong F,et al.Glucose metabolism disorder in obese children assessed by continuous glucose monitoring system.World J Pediatr,2008,4:26-30.
  • 2Knoflach M,Kiechl S,Kind M,et al.Cardiovascular risk factors and atheroscleresis in young males:ARMY study(Atherosclerosis Risk-Factors in Male Youngsters).Circulation,2003,108:1064-1069.
  • 3Steinberger J,Daniels SR.Obesity,insulin resistance,diabetes,and cardiovascular risk in children:an American Heart Association scientific statement from the Atheroacleresis,Hypertension,and Obesity in the Young Committee(Council on Cardiovascular Disease in the Young)and the Diabetes Committee(Council on Nutrition,Physical Activity,and Metabolism).Circulation,2003,107:1448-1453.
  • 4Abdou AS,Magour GM,Mahmoud MM.Evaluation of some markers of subclinical atherosclerosis in Egyptian young adult males with abdominal obesity.Br J Biomed Sci,2009,66:143-147.
  • 5Eckel RH,Grundy SM,Zimmet PZ.The metabolic syndrome.Lancet,2005,365:1415-1428.
  • 6McGarry JD.Banting lecture 2001:dysregulation of fatty acid metabolism in the etiology of type 2 diabetes.Diabetes,2002,51:7-18.
  • 7Zhou MS,Schulman IH,Raij L.Vascular inflammation,insulin resistance,and endothelial dysfunction in salt-sensitive hypertension:role of nuclear factor kappa B activation.J Hypertens,2009.
  • 8Quijada Z,Paoli M,Zerpa Y,et al.The triglyeeride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children;association with traditional and emergent risk factors.Pediatr Diabetes,2008.9:464-471.
  • 9Holvoet P,De Keyzer D,Jacobs DR.Oxidized LDL and the metabohc syndrome.Future Lipidol,2008,3:637-649.
  • 10Cardoso-Saldana G,Juarez-Rojas JG,Zamora-Gonzalez J,et al.C-reactive protein levels and their relatiomhip with metabolic syndrome and insulin resistance in Mexican adolescents.J Pediatr Endocrinol Metab,2007,20:797-805.

共引文献753

同被引文献21

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部